CMR Molecular Imaging

What CMR Molecular Imaging does

CMR Molecular Imaging is a privately-held medical imaging company headquartered in Carlsbad, California, founded in 1973. The company provides high-resolution PET (Positron Emission Tomography) scanners engineered for exceptional visualization of small body parts, positioning it within the broader functional brain imaging system market. According to available market context, this market is projected to grow from USD 2,180.7 million in 2025 to USD 3,420.6 million by 2035 at a 4.5% CAGR, with fMRI technology leading at 49.7% of market share. CMR's served end-user base skews to hospitals, which command 52.7% of functional brain imaging demand, with neurology applications representing 44.9% of the market by use case and being driven by needs in neurological and psychiatric disorder diagnosis and monitoring.

The company's core technical offering is a dedicated high-resolution PET scanner optimized for small-anatomy imaging, distinguishing it from general-purpose PET/CT systems sold by large incumbents. In October 2017, CMR expanded its technology footprint via the acquisition of Gamma Medica, a molecular imaging specialist, for an undisclosed amount. The company's website (cmr-naviscan.com) currently serves only as a verification page, and no detailed product specifications, pricing, distribution model, headcount, funding history, or financial disclosures are available in the source material.

Revenue mechanics, go-to-market channels, and customer concentration are not documented. The company appears to operate as a specialty OEM selling capital equipment into hospital radiology and nuclear medicine departments, likely through a direct sales model and potentially distributor relationships, but this is inferred rather than confirmed. The most material observable fact is the long operating history (over 50 years), the niche product positioning around high-resolution small-body-part PET, and the 2017 Gamma Medica acquisition, against an otherwise sparse public information profile.

Name

CMR Molecular Imaging

Website

https://cmr-naviscan.com

Company type

Private

Founded year

1973

Headcount range

11–50 employees

Short description

CMR Molecular Imaging is a privately-held medical device company, founded in 1973 in Carlsbad, California, that develops high-resolution PET scanners for visualization of small body parts, serving hospital-based neurology and diagnostic imaging applications.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)

Keywords

• Molecular imaging systems
• PET scanners
• Functional brain imaging
• High-resolution imaging equipment
• Neurological imaging devices

Headquarters

HQ city

Carlsbad

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel

Core offering

CMR Molecular Imaging provides a high-resolution PET scanner that delivers exceptional visualization of small body parts, serving as a functional brain imaging system for neurological and psychiatric disorder diagnosis. The company's offering is positioned within the functional brain imaging system market, which is targeted primarily at hospital end-users and neurology applications.

Product overview

No product information available. The source data does not contain specific product details for CMR Molecular Imaging. The available webpage content consists of a verification/loading page (cmr-naviscan.com), and the news article provides only general market context for the functional brain imaging system market without detailing CMR Molecular Imaging's specific product portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

• High-Resolution PET Scanner

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves1 record

Expansion highlights3 records

Broad incumbents

• GE HealthCare: GE HealthCare is a global medical imaging OEM with a broad portfolio that includes PET/CT systems. It is comparable to CMR Molecular Imaging as a much larger incumbent in the molecular imaging equipment market, competing for hospital capital budgets in nuclear medicine.
• Siemens Healthineers: Siemens Healthineers manufactures a full line of diagnostic imaging systems including PET, SPECT, and hybrid PET/CT. It competes with CMR Molecular Imaging across molecular imaging hardware, particularly in hospital and specialty imaging deployments.
• Philips Healthcare: Philips Healthcare offers a broad diagnostic imaging portfolio including PET and hybrid molecular imaging systems. As a full-suite imaging OEM, it competes with CMR Molecular Imaging for the same hospital and specialty clinic capital purchasing decisions.
• Canon Medical Systems: Canon Medical Systems produces diagnostic imaging equipment including PET/CT systems. It is a comparable broad-line imaging incumbent that competes with CMR Molecular Imaging in molecular imaging capital sales.

Emerging players

• United Imaging Healthcare: United Imaging Healthcare is a China-based imaging OEM that has rapidly expanded into PET/CT and other molecular imaging modalities. It is comparable to CMR Molecular Imaging as a growing entrant in PET imaging equipment targeting hospital customers.
• Cubresa: Cubresa develops preclinical PET imaging systems for research and translational applications. It is comparable to CMR Molecular Imaging as a smaller, focused player in the high-resolution, small-specimen PET imaging niche.
• MR Solutions: MR Solutions manufactures preclinical MRI and PET imaging systems for research institutions. It is a comparable emerging player serving the same high-resolution, small-animal and dedicated molecular imaging markets as CMR Molecular Imaging.

Direct peers

• Bruker Corporation: Bruker manufactures preclinical and molecular imaging systems, including PET, SPECT, and MRI for research and specialty clinical use. It is highly comparable to CMR Molecular Imaging's specialty/preclinical PET focus, particularly in the small-animal and dedicated-organ imaging segments served via the Gamma Medica lineage.
• Mediso Medical Imaging Systems: Mediso makes preclinical and clinical molecular imaging systems including dedicated PET and SPECT scanners. It directly competes with CMR Molecular Imaging in small-animal, organ-dedicated, and specialty clinical PET imaging.
• Positron Corporation: Positron Corporation focuses on PET and nuclear medicine imaging equipment for cardiac and specialty clinical applications. It is a direct peer to CMR Molecular Imaging as a small, focused PET equipment vendor targeting niche clinical imaging indications.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/cmr-naviscan-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CMR Molecular Imaging